Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada

• Asıl Yazarlar: Virender Bhan (Yazar), Fraser Clift (Yazar), Moogeh Baharnoori (Yazar), Kimberly Thomas (Yazar), Barkha P Patel (Yazar), Francois Blanchette (Yazar), Nicholas Adlard (Yazar), Umakanth Vudumula (Yazar), Kapil Gudala (Yazar), Nikkita Dutta (Yazar), Daniel Grima (Yazar), Soukaina Mouallif (Yazar), Fatine Farhane (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Becaris Publishing Limited, 2023-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Aim: The costs and consequences of initial and delayed ofatumumab treatment were evaluated in relapsing-remitting multiple sclerosis with active disease in Canada. Materials & methods: A Markov cohort model was used (10-year horizon, annual cycle length, 1.5% discounting). Scenario analyses exam...